Company Filing History:
Years Active: 2022
Title: The Innovations of Joao Antonio Lourenco Goncalves
Introduction
Joao Antonio Lourenco Goncalves is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of genetic research, specifically through his innovative patent in therapeutic treatments.
Latest Patents
Goncalves holds a patent for "Therapeutic splice-switching oligonucleotides." This patent presents compositions and methods aimed at treating disorders associated with mutations in the CEP290 gene. The invention includes synthetic polynucleotides designed to skip a reading frame of a CEP290 pre-RNA, resulting in a translated product that lacks specific exons. Additionally, the patent details methods for administering these synthetic polynucleotides to patients for effective treatment.
Career Highlights
Joao Antonio Lourenco Goncalves currently works at Deep Genomics Incorporated, where he contributes his expertise in genetic innovations. His work focuses on the intersection of gene therapy and oligonucleotide technology, enabling advancements in medical treatments for genetic disorders.
Collaborations
In his career at Deep Genomics, Goncalves collaborates with talented professionals such as Daniele Merico and Erno Wienholds. These collaborations have been crucial in enhancing research outcomes and driving forward innovative solutions in the realm of genetic diseases.
Conclusion
Joao Antonio Lourenco Goncalves exemplifies the spirit of innovation with his contributions to genetic research and therapy. His patent on therapeutic splice-switching oligonucleotides not only highlights his inventive capabilities but also opens new pathways for treating genetic disorders. As he continues to work at Deep Genomics, his future contributions are sure to impact the field positively.